Phenylephrine	phenylephrine	CHEMICALS	O	OTHERS	I
but	but	O	O	O	O
not	not	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
reduces	reduces	O	O	OTHERS	I
frontal	frontal	O	O	OTHERS	I
lobe	lobe	O	O	OTHERS	I
oxygenation	oxygenation	O	O	OTHERS	I
following	following	O	O	O	O
anesthesia-induced	anesthesia-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Vasopressor	vasopressor	O	O	O	O
agents	agents	O	O	O	O
are	are	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
correct	correct	O	O	O	O
anesthesia-induced	anesthesia-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
describe	describe	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
phenylephrine	phenylephrine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
frontal	frontal	O	O	O	O
lobe	lobe	O	O	O	O
oxygenation	oxygenation	O	O	O	O
(	(	O	O	O	O
S(c)O(2	s(c)o(2	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
following	following	O	O	O	O
anesthesia-induced	anesthesia-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
Following	following	O	O	O	O
induction	induction	O	O	O	O
of	of	O	O	O	O
anesthesia	anesthesia	O	O	O	O
by	by	O	O	O	O
fentanyl	fentanyl	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.15	0.15	O	O	O	O
mg	mg	O	O	OTHERS	I
kg(-1	kg(-1	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
propofol	propofol	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
2.0	2.0	O	O	O	O
mg	mg	O	O	OTHERS	I
kg(-1	kg(-1	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
13	13	O	O	O	O
patients	patients	O	O	O	O
received	received	O	O	O	O
phenylephrine	phenylephrine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.1	0.1	O	O	O	O
mg	mg	O	O	OTHERS	I
iv	iv	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
12	12	O	O	O	O
patients	patients	O	O	O	O
received	received	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
10	10	O	O	O	O
mg	mg	O	O	OTHERS	I
iv	iv	O	O	O	O
)	)	O	O	O	O
to	to	O	O	O	O
restore	restore	O	O	O	O
mean	mean	O	O	O	O
arterial	arterial	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
MAP	map	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Heart	heart	O	O	O	O
rate	rate	O	O	O	O
(	(	O	O	O	O
HR	hr	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
MAP	map	O	O	OTHERS	I
,	,	O	O	O	O
stroke	stroke	O	DISEASE	OTHERS	I
volume	volume	O	O	O	O
(	(	O	O	O	O
SV	sv	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
cardiac	cardiac	O	O	O	O
output	output	O	O	O	O
(	(	O	O	O	O
CO	co	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
frontal	frontal	O	O	O	O
lobe	lobe	O	O	O	O
oxygenation	oxygenation	O	O	O	O
(	(	O	O	O	O
S(c)O(2	s(c)o(2	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
registered	registered	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Induction	induction	O	O	O	O
of	of	O	O	O	O
anesthesia	anesthesia	O	O	O	O
was	was	O	O	O	O
followed	followed	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
MAP	map	O	O	OTHERS	I
,	,	O	O	O	O
HR	hr	O	O	O	O
,	,	O	O	O	O
SV	sv	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
CO	co	CHEMICALS	O	OTHERS	I
concomitant	concomitant	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
elevation	elevation	O	O	O	O
in	in	O	O	O	O
S(c)O(2	s(c)o(2	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
phenylephrine	phenylephrine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
MAP	map	O	O	OTHERS	I
increased	increased	O	O	O	O
(	(	O	O	O	O
51	51	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
12	12	O	O	O	O
to	to	O	O	O	O
81	81	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
13	13	O	O	O	O
mmHg	mmhg	O	O	O	O
;	;	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.001	0.001	O	O	O	O
;	;	O	O	O	O
mean	mean	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
SD	sd	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
14	14	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
from	from	O	O	O	O
70	70	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
8	8	O	O	O	O
%	%	O	O	O	O
to	to	O	O	O	O
60	60	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
7	7	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
S(c)O(2	s(c)o(2	O	O	O	O
)	)	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
followed	followed	O	O	O	O
with	with	O	O	O	O
no	no	O	O	O	O
change	change	O	O	O	O
in	in	O	O	O	O
CO	co	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
3.7	3.7	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
1.1	1.1	O	O	O	O
to	to	O	O	O	O
3.4	3.4	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.9	0.9	O	O	O	O
l	l	O	O	O	O
min(-1	min(-1	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
led	led	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
similar	similar	O	O	O	O
increase	increase	O	O	OTHERS	I
in	in	O	O	OTHERS	I
MAP	map	O	O	OTHERS	I
(	(	O	O	O	O
53	53	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
9	9	O	O	O	O
to	to	O	O	O	O
79	79	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
8	8	O	O	O	O
mmHg	mmhg	O	O	O	O
;	;	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.001	0.001	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
restored	restored	O	O	O	O
CO	co	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
3.2	3.2	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
1.2	1.2	O	O	O	O
to	to	O	O	O	O
5.0	5.0	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
1.3	1.3	O	O	O	O
l	l	O	O	O	O
min(-1	min(-1	O	O	O	O
)	)	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
preserved	preserved	O	O	O	O
S(c)O(2	s(c)o(2	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
utilization	utilization	O	O	O	O
of	of	O	O	O	O
phenylephrine	phenylephrine	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
correct	correct	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
anesthesia	anesthesia	O	O	O	O
has	has	O	O	O	O
a	a	O	O	O	O
negative	negative	O	O	O	O
impact	impact	O	O	O	O
on	on	O	O	O	O
S(c)O(2	s(c)o(2	O	O	O	O
)	)	O	O	O	O
while	while	O	O	O	O
ephedrine	ephedrine	CHEMICALS	O	OTHERS	I
maintains	maintains	O	O	O	O
frontal	frontal	O	O	O	O
lobe	lobe	O	O	O	O
oxygenation	oxygenation	O	O	O	O
potentially	potentially	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
CO	co	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

